Skip to main content
. 2022 Apr 12;18:867–879. doi: 10.2147/NDT.S337703

Figure 1.

Figure 1

Screening, decision-making algorithm for vortioxetine, and monitoring patients with MDD. *Nausea, constipation, vomiting, diarrhea, dry mouth, and dizziness.18

Note: These are commonly reported adverse reactions with serotonergic antidepressants.29

Abbreviation: MDD, major depressive disorder.